Gene therapy restores vision to mice with retinal de... ( Massachusetts General Hospital (MGH)...)

Gene therapy restores vision to mice with retinal degeneration

Date:10/16/2008

Massachusetts General Hospital (MGH) researchers have used gene therapy to restore useful vision to mice with degeneration of the light-sensing retinal rods and cones, a common cause of human blindness. Their report, appearing in the Oct. 14 Proceedings of the National Academy of Sciences, describes the effects of broadly expressing a light-sensitive protein in other neuronal cells found throughout the retina.

"This is a proof of principle that someday we may be able to repair blindness in people with conditions like retinitis pigmentosa and macular degeneration," says Richard Masland, PhD, director of the Cellular Neurobiology Laboratory in the MGH Department of Neurosurgery. "There are several limitations we need to overcome before we can begin clinical trials, but I'm optimistic that this work may someday make a big difference for people who otherwise would have no vision at all."

The study was designed to investigate the effect of expressing the light-sensitive protein melanopsin in retinal ganglion cells. These specialized neurons receive light signals from the rods and cones and carry those signals into the brain via the optic nerve, which is formed from the cells' axons. Melanopsin is usually produced in a subset of cells that are involved with establishing circadian rhythms but not with vision. The MGH team used the standard viral vector adeno-associated virus to deliver the gene encoding melanopsin throughout the retinas of mice whose rod and cone photoreceptors had degenerated from lack of a crucial protein.

Four weeks after delivery of the gene, melanopsin normally produced in 1 percent of retinal ganglion cells was found in about 10 percent of ganglion cells in the treated eyes but not in eyes that received a sham injection. Many of the melanopsin-expressing cells were structurally different from those that typically produce the protein, implying that it was being expressed in a broader range of retinal ga
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

1

GOOD

Page: 1 2
Related biology news :

1. A new radiation therapy treatment developed for head and neck cancer patients
2. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. MIT works toward safer gene therapy
5. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
6. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
7. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
8. Safe and effective therapy discovered for patients with protein-losing enteropathy
9. Ireland Cancer Center researchers advance stem cell gene therapy
10. Dolphin therapy a dangerous fad, Emory researchers warn
11. Cancer and arthritis therapy may be promising treatment for diabetes

Post Your Comments:

(Date:2/9/2010)... majority owned subsidiary of Avisio, Inc. acquired an ... , The technology is based on an ... e.g. mosquitos and black flies, utilize their olfactory ... animals and humans. CO2, which is a major ... insect to its prey. , Developed by ...

(Date:2/8/2010)... Mediterranean diet may help people avoid the small areas ... thinking and memory, according to a study released today ... Neurology,s 62nd Annual Meeting in Toronto April 10 to ... people who ate a Mediterranean-like diet were less likely ... tissue linked to thinking problems. , The Mediterranean ...

(Date:2/8/2010)... With the recent election of Senator ... in the loss of the Democratic supermajority, the urgency ... universal coverage for the majority of uninsured Americans has ... President Obama recently noted the country is closer than ... for many a long sought after social reform, and ...

[0] UC Riverside licenses technology to OlFactor Laboratories, Inc.[0] Mediterranean diet may lower risk of brain damage that causes thinking problems [0] S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now?

... reported findings that offer a surprising new twist to ... select the flowers from which they collect nectar. When ... flowers entirely alone but instead copy the choices of ... their behavior when dealing with flowers of unfamiliar plant ...

... paths some 5 million to 6 million years ago, we ... and acquired a knack for abstract thought while our next ... to construct tree-bound nests high above the forest floor. We ... sequence level, yet scientists predict that both species should harbor ...

... River varies in time, what causes those variations, and ... deforestation is a focus of study for scientists at ... in the last several decades have led to significant ... eastern and southern portion of the basin. By using ...

Other Biology News:Can our genes tell the story of our divergence? 2 Assessing the Amazon River's sensitivity to deforestation 2

Bumblebees copy one another when contending with unfamiliar flowers Can our genes tell the story of our divergence?Assessing the Amazon River's sensitivity to deforestation

(Date:2/9/2010)... Feb. 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE ... an international,biopharmaceutical company with operations in the U.S. ... cell collection network has expanded into the southwestern,region ... physician group at Westlake,Orthopaedics Spine & Sports ("Westlake") ... is on,track to achieve its target of 10 ...

(Date:2/8/2010)... /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE Alternext: TPI), ... based in Chengdu, China ,today announced fiscal results ... . , , -- Q2 2010 ... 24.8% to $2.6 ... basis, -- Cash and Equivalents of ...

(Date:2/8/2010)... label-free biomolecular interaction analysis now offers surface chemistries for: ... and Protein G for coupling antibodies. , ... ... February 8, 2010 -- Silicon Kinetics Inc., the pioneering ... first 3D biosensor surface for label-free biomolecular interaction analysis, ...

(Date:2/8/2010)... NEW ORLEANS , Feb. 8 /PRNewswire-FirstCall/ ... worldwide developer and marketer of diagnostic test kits, and ... of the collaborative effort to combat viral hemorrhagic fever ... $800,000 in contract revenue for Corgenix over the ... of Health (NIH) has awarded a five-year contract totaling ...

[0] Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network [0] Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results [0] Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries [0] Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents

... Nov. 26 Evalve, Inc., the leader in,the ... cardiac valves,announced today that the first three patients ... the University of Hull, Castle Hill Hospital,in the ... commercially,available medical device which provides a non-surgical mitral ...

... an update on internal policy and clinical, ... Symbol: RVX , , CALGARY, ... that the previously announced internal blackout trading restriction of April ... regional and global partnerships are actively ongoing and should the ...

... Nov. 26 Thomas K. Equels, President and Managing,Director ... the board of directors,for Hemispherx BioPharma, Inc. (Amex: ... manufacture and clinical development,of new drug entities for the ... Equels, legal practice is devoted ...

Other Biology Technology:First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 2 First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 3 Resverlogix Board of Directors Update 2 Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2 Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3

First United Kingdom Patients Treated With Percutaneous MitraClip(R) System Resverlogix Board of Directors Update Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors

...

... allow for the rapid isolation of DNA from ... slice in the spin filter, centrifuge for 3 ... recovered. There is no need to melt agarose ... can also be used for buffer exchange, primer ...

ChemiArray Human Cytokine Antibody Array VII, 60 cytokines per membrane...

Biology Products:

Suramin, Sodium Salt from Calbiochem cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio Easy Clean DNA Spin Filter from Primm Labs Human Atherosclerosis Antibody Array I Kit, ChemiArray, 20 cytokines per membrane from CHEMICON

Gene therapy restores vision to mice with retinal de...( Massachusetts General Hospital (MGH)...)